Viatris is recalling 21,094 units of Candesartan Cilexetil (16 mg), a medication used to treat high blood pressure, because the tablets failed to meet impurity and degradation specifications. The recall specifically affects 30-count bottles manufactured for Mylan Pharmaceuticals Inc. No incidents or injuries have been reported to date regarding this issue.
The tablets were found to have levels of a related impurity compound that exceeded safety specifications. Taking medication with unexpected impurities may lead to unknown long-term health effects.
You have 2 options:
Manufactured for Mylan Pharmaceuticals Inc., Morgantown, WV 26505
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.